Clinical Trial Update: A Study to Evaluate MTM-H-001 Injection in Adult Participants With Relapsed or Refractory B-cell Malignancies [NA]

View source ↗

Summary

This clinical trial update describes an evaluation of MTM-H-001 injection in adults with relapsed or refractory B-cell lymphomas, with the study currently not y…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma
• Mantle Cell Lymphoma
• Marginal Zone B-cell Lymphoma
• Small Lymphocytic Lymphoma
• Transformed Follicular Lymphoma

Drugs mentioned

• MTM-H-001

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma, Follicular | NA | Status: NOT_YET_RECRUITING